NeuroMetrix (NASDAQ:NURO) Receives New Coverage from Analysts at StockNews.com

StockNews.com assumed coverage on shares of NeuroMetrix (NASDAQ:NURO) in a research note released on Saturday morning. The firm issued a sell rating on the medical device company’s stock.

NeuroMetrix Price Performance

NASDAQ NURO opened at $3.60 on Friday. The stock has a market capitalization of $7.24 million, a P/E ratio of -0.57 and a beta of 2.30. The firm’s 50-day moving average is $4.02 and its two-hundred day moving average is $3.72. NeuroMetrix has a 12 month low of $2.70 and a 12 month high of $8.00.

NeuroMetrix (NASDAQ:NURO) last posted its quarterly earnings data on Wednesday, May 15th. The medical device company reported ($1.67) earnings per share for the quarter. The company had revenue of $1.09 million for the quarter. NeuroMetrix had a negative return on equity of 39.85% and a negative net margin of 151.51%.

Hedge Funds Weigh In On NeuroMetrix

A hedge fund recently bought a new stake in NeuroMetrix stock. Cerity Partners LLC purchased a new position in shares of NeuroMetrix, Inc. (NASDAQ:NURO) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 30,000 shares of the medical device company’s stock, valued at approximately $108,000. Cerity Partners LLC owned 2.80% of NeuroMetrix at the end of the most recent reporting period. Institutional investors own 19.40% of the company’s stock.

NeuroMetrix Company Profile

NeuroMetrix, Inc, a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, and China. Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system offers services to device and provide disposable electrodes to a customer base of hand surgeons and manufacturers for industrial health use.